P-291 - NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option. - Weinberg, B.; Renouf, D.; Lim, H.; Heining, C.; Schlenk, R.; Jones, M.; Liu, S.; Cseh, A.; Solca, F.; Laskin, J. (Annals of Oncology, 2019)